Latest on the Corona Virus
Collapse
X
-
-
Re: Latest on the Corona Virus
Newsflash. Most Americans don't plan to wear a mask this flu season. Apparently masks don't work.Adversity temporarily visits a strong man but stays with the weak for a lifetime.Comment
-
Re: Latest on the Corona Virus
NIAID director Anthony Fauci said Tuesday that "we should not be surprised" if a new COVID-19 variant emerges this winter.
Driving the news: "We should anticipate that we very well may get another variant that would emerge that would elude the immune response that we've gotten from infection and/or from vaccination," Fauci said during an event with the USC Annenberg Center for Health Journalism.
Fauci said it we're currently moving "in the right direction,"
But, but, but: "We are entering into the winter months, where no matter what the respiratory disease is, there's always a risk of an uptick."Comment
-
Re: Latest on the Corona Virus
Horowitz: 5 shocking new studies and data points that nuke the COVID shots - Conservative ReviewComment
-
Re: Latest on the Corona Virus
ICAN Wins Lawsuit Forcing CDC to Turn Over V-SAFE Covid Vaccine Injury Data - Truth PressComment
-
Re: Latest on the Corona Virus
Fauci's NIH gives another $3.5 million to EcoHealth despite dangerous past of coronavirus research | Sara A. Carter
Sent from my SM-G990U using TapatalkComment
-
Re: Latest on the Corona Virus
Fauci's NIH gives another $3.5 million to EcoHealth despite dangerous past of coronavirus research | Sara A. Carter
Sent from my SM-G990U using TapatalkComment
-
Comment
-
Re: Latest on the Corona Virus
Comment
-
Re: Latest on the Corona Virus
A rebound of COVID-19 symptoms in some patients after taking Pfizer's antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on Thursday.
They concluded that taking a longer course of the drug - beyond the recommended five days - was not required to reduce the risk of a recurrence of symptoms as some have suggested, based on an intensive investigation of rebound in eight patients at the National Institutes of Health's Clinical Center.Comment
Comment